TCL Archive In Brief: President Clinton Appoints Six New Members To The National Cancer Advisory Board December 11, 1998
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI January 18, 1991